3.22.0.1 html 240 505 1 false 78 0 false 9 false false R1.htm 0001001 - Document - Cover Sheet http://www.antarespharma.com/role/Cover Cover Cover 1 false false R2.htm 0002002 - Document - Audit Information Sheet http://www.antarespharma.com/role/AuditInformation Audit Information Notes 2 false false R3.htm 1001003 - Statement - Consolidated Balance Sheets Sheet http://www.antarespharma.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets Uncategorized 3 false false R4.htm 1002004 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.antarespharma.com/role/ConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Cover 4 false false R5.htm 1003005 - Statement - Consolidated Statements of Operations Sheet http://www.antarespharma.com/role/ConsolidatedStatementsofOperations Consolidated Statements of Operations Statements 5 false false R6.htm 1004006 - Statement - Consolidated Statements of Comprehensive Income (Loss) Sheet http://www.antarespharma.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss Consolidated Statements of Comprehensive Income (Loss) Statements 6 false false R7.htm 1005007 - Statement - Consolidated Statements of Stockholders' Equity Sheet http://www.antarespharma.com/role/ConsolidatedStatementsofStockholdersEquity Consolidated Statements of Stockholders' Equity Statements 7 false false R8.htm 1006008 - Statement - Consolidated Statements of Cash Flows Sheet http://www.antarespharma.com/role/ConsolidatedStatementsofCashFlows Consolidated Statements of Cash Flows Statements 8 false false R9.htm 2101101 - Disclosure - Description of Business Sheet http://www.antarespharma.com/role/DescriptionofBusiness Description of Business Notes 9 false false R10.htm 2102102 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.antarespharma.com/role/SummaryofSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 10 false false R11.htm 2109103 - Disclosure - Inventories Sheet http://www.antarespharma.com/role/Inventories Inventories Notes 11 false false R12.htm 2113104 - Disclosure - Property and Equipment Sheet http://www.antarespharma.com/role/PropertyandEquipment Property and Equipment Notes 12 false false R13.htm 2117105 - Disclosure - Leases Sheet http://www.antarespharma.com/role/Leases Leases Notes 13 false false R14.htm 2121106 - Disclosure - Intangible Assets Sheet http://www.antarespharma.com/role/IntangibleAssets Intangible Assets Notes 14 false false R15.htm 2126107 - Disclosure - Accrued Expenses and Other Current Liabilities Sheet http://www.antarespharma.com/role/AccruedExpensesandOtherCurrentLiabilities Accrued Expenses and Other Current Liabilities Notes 15 false false R16.htm 2129108 - Disclosure - Long-Term Debt Sheet http://www.antarespharma.com/role/LongTermDebt Long-Term Debt Notes 16 false false R17.htm 2133109 - Disclosure - Stockholders' Equity Sheet http://www.antarespharma.com/role/StockholdersEquity Stockholders' Equity Notes 17 false false R18.htm 2135110 - Disclosure - Share Based Compensation Sheet http://www.antarespharma.com/role/ShareBasedCompensation Share Based Compensation Notes 18 false false R19.htm 2143111 - Disclosure - Employee 401(k) Savings Plan Sheet http://www.antarespharma.com/role/Employee401kSavingsPlan Employee 401(k) Savings Plan Notes 19 false false R20.htm 2145112 - Disclosure - Sale of Assets Sheet http://www.antarespharma.com/role/SaleofAssets Sale of Assets Notes 20 false false R21.htm 2147113 - Disclosure - Income Taxes Sheet http://www.antarespharma.com/role/IncomeTaxes Income Taxes Notes 21 false false R22.htm 2155114 - Disclosure - Revenues, Significant Customers and Concentrations of Risk Sheet http://www.antarespharma.com/role/RevenuesSignificantCustomersandConcentrationsofRisk Revenues, Significant Customers and Concentrations of Risk Notes 22 false false R23.htm 2159115 - Disclosure - Earnings (Loss) per Share Sheet http://www.antarespharma.com/role/EarningsLossperShare Earnings (Loss) per Share Notes 23 false false R24.htm 2162116 - Disclosure - Commitments and Contingencies Sheet http://www.antarespharma.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 24 false false R25.htm 2203201 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.antarespharma.com/role/SummaryofSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.antarespharma.com/role/SummaryofSignificantAccountingPolicies 25 false false R26.htm 2304301 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.antarespharma.com/role/SummaryofSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://www.antarespharma.com/role/SummaryofSignificantAccountingPolicies 26 false false R27.htm 2310302 - Disclosure - Inventories (Tables) Sheet http://www.antarespharma.com/role/InventoriesTables Inventories (Tables) Tables http://www.antarespharma.com/role/Inventories 27 false false R28.htm 2314303 - Disclosure - Property and Equipment (Tables) Sheet http://www.antarespharma.com/role/PropertyandEquipmentTables Property and Equipment (Tables) Tables http://www.antarespharma.com/role/PropertyandEquipment 28 false false R29.htm 2318304 - Disclosure - Leases (Tables) Sheet http://www.antarespharma.com/role/LeasesTables Leases (Tables) Tables http://www.antarespharma.com/role/Leases 29 false false R30.htm 2322305 - Disclosure - Intangible Assets (Tables) Sheet http://www.antarespharma.com/role/IntangibleAssetsTables Intangible Assets (Tables) Tables http://www.antarespharma.com/role/IntangibleAssets 30 false false R31.htm 2327306 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables) Sheet http://www.antarespharma.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables Accrued Expenses and Other Current Liabilities (Tables) Tables http://www.antarespharma.com/role/AccruedExpensesandOtherCurrentLiabilities 31 false false R32.htm 2330307 - Disclosure - Long-Term Debt (Tables) Sheet http://www.antarespharma.com/role/LongTermDebtTables Long-Term Debt (Tables) Tables http://www.antarespharma.com/role/LongTermDebt 32 false false R33.htm 2336308 - Disclosure - Share Based Compensation (Tables) Sheet http://www.antarespharma.com/role/ShareBasedCompensationTables Share Based Compensation (Tables) Tables http://www.antarespharma.com/role/ShareBasedCompensation 33 false false R34.htm 2348309 - Disclosure - Income Taxes (Tables) Sheet http://www.antarespharma.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://www.antarespharma.com/role/IncomeTaxes 34 false false R35.htm 2356310 - Disclosure - Revenues, Significant Customers and Concentrations of Risk (Tables) Sheet http://www.antarespharma.com/role/RevenuesSignificantCustomersandConcentrationsofRiskTables Revenues, Significant Customers and Concentrations of Risk (Tables) Tables http://www.antarespharma.com/role/RevenuesSignificantCustomersandConcentrationsofRisk 35 false false R36.htm 2360311 - Disclosure - Earnings (Loss) per Share (Tables) Sheet http://www.antarespharma.com/role/EarningsLossperShareTables Earnings (Loss) per Share (Tables) Tables http://www.antarespharma.com/role/EarningsLossperShare 36 false false R37.htm 2405401 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail) Sheet http://www.antarespharma.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail Summary of Significant Accounting Policies - Additional Information (Detail) Details 37 false false R38.htm 2406402 - Disclosure - Summary of Significant Accounting Policies - Remaining Performance Obligations (Detail) Sheet http://www.antarespharma.com/role/SummaryofSignificantAccountingPoliciesRemainingPerformanceObligationsDetail Summary of Significant Accounting Policies - Remaining Performance Obligations (Detail) Details 38 false false R39.htm 2407403 - Disclosure - Summary of Significant Accounting Policies - Summary of Estimated Useful Lives of Property and Equipment (Details) Sheet http://www.antarespharma.com/role/SummaryofSignificantAccountingPoliciesSummaryofEstimatedUsefulLivesofPropertyandEquipmentDetails Summary of Significant Accounting Policies - Summary of Estimated Useful Lives of Property and Equipment (Details) Details 39 false false R40.htm 2408404 - Disclosure - Summary of Significant Accounting Policies - Summary of Changes in Reserves for Product Returns and Sales Allowances (Detail) Sheet http://www.antarespharma.com/role/SummaryofSignificantAccountingPoliciesSummaryofChangesinReservesforProductReturnsandSalesAllowancesDetail Summary of Significant Accounting Policies - Summary of Changes in Reserves for Product Returns and Sales Allowances (Detail) Details 40 false false R41.htm 2411405 - Disclosure - Inventories - Summary of Inventories (Detail) Sheet http://www.antarespharma.com/role/InventoriesSummaryofInventoriesDetail Inventories - Summary of Inventories (Detail) Details 41 false false R42.htm 2412406 - Disclosure - Inventories - Additional Information (Detail) Sheet http://www.antarespharma.com/role/InventoriesAdditionalInformationDetail Inventories - Additional Information (Detail) Details 42 false false R43.htm 2415407 - Disclosure - Property and Equipment - Summary of Property and Equipment (Detail) Sheet http://www.antarespharma.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetail Property and Equipment - Summary of Property and Equipment (Detail) Details 43 false false R44.htm 2416408 - Disclosure - Property and Equipment - Additional Information (Detail) Sheet http://www.antarespharma.com/role/PropertyandEquipmentAdditionalInformationDetail Property and Equipment - Additional Information (Detail) Details 44 false false R45.htm 2419409 - Disclosure - Leases - Additional Information (Detail) Sheet http://www.antarespharma.com/role/LeasesAdditionalInformationDetail Leases - Additional Information (Detail) Details 45 false false R46.htm 2420410 - Disclosure - Leases - Summary of Operating Lease Maturities (Detail) Sheet http://www.antarespharma.com/role/LeasesSummaryofOperatingLeaseMaturitiesDetail Leases - Summary of Operating Lease Maturities (Detail) Details 46 false false R47.htm 2423411 - Disclosure - Intangible Assets - Schedule of Intangible Assets (Detail) Sheet http://www.antarespharma.com/role/IntangibleAssetsScheduleofIntangibleAssetsDetail Intangible Assets - Schedule of Intangible Assets (Detail) Details 47 false false R48.htm 2424412 - Disclosure - Intangible Assets - Additional Information (Detail) Sheet http://www.antarespharma.com/role/IntangibleAssetsAdditionalInformationDetail Intangible Assets - Additional Information (Detail) Details 48 false false R49.htm 2425413 - Disclosure - Intangible Assets - Schedule of Estimated Future Aggregate Amortization Expense (Detail) Sheet http://www.antarespharma.com/role/IntangibleAssetsScheduleofEstimatedFutureAggregateAmortizationExpenseDetail Intangible Assets - Schedule of Estimated Future Aggregate Amortization Expense (Detail) Details 49 false false R50.htm 2428414 - Disclosure - Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Liabilities (Detail) Sheet http://www.antarespharma.com/role/AccruedExpensesandOtherCurrentLiabilitiesScheduleofAccruedExpensesandOtherLiabilitiesDetail Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Liabilities (Detail) Details 50 false false R51.htm 2431415 - Disclosure - Long-Term Debt - Additional Information (Detail) Sheet http://www.antarespharma.com/role/LongTermDebtAdditionalInformationDetail Long-Term Debt - Additional Information (Detail) Details 51 false false R52.htm 2432416 - Disclosure - Long-Term Debt - Schedule of Future Principal Payments under Term Loan, Excluding End of Term Charge (Detail) Sheet http://www.antarespharma.com/role/LongTermDebtScheduleofFuturePrincipalPaymentsunderTermLoanExcludingEndofTermChargeDetail Long-Term Debt - Schedule of Future Principal Payments under Term Loan, Excluding End of Term Charge (Detail) Details 52 false false R53.htm 2434417 - Disclosure - Stockholders' Equity - Additional Information (Detail) Sheet http://www.antarespharma.com/role/StockholdersEquityAdditionalInformationDetail Stockholders' Equity - Additional Information (Detail) Details 53 false false R54.htm 2437418 - Disclosure - Share Based Compensation - Additional Information (Detail) Sheet http://www.antarespharma.com/role/ShareBasedCompensationAdditionalInformationDetail Share Based Compensation - Additional Information (Detail) Details 54 false false R55.htm 2438419 - Disclosure - Share Based Compensation - Summary of Stock Option Activity (Detail) Sheet http://www.antarespharma.com/role/ShareBasedCompensationSummaryofStockOptionActivityDetail Share Based Compensation - Summary of Stock Option Activity (Detail) Details 55 false false R56.htm 2439420 - Disclosure - Share Based Compensation - Assumptions Used in Fair Value Measurement of Options Granted (Detail) Sheet http://www.antarespharma.com/role/ShareBasedCompensationAssumptionsUsedinFairValueMeasurementofOptionsGrantedDetail Share Based Compensation - Assumptions Used in Fair Value Measurement of Options Granted (Detail) Details 56 false false R57.htm 2440421 - Disclosure - Share Based Compensation - Schedule of Performance Stock Unit Awards and Restricted Stock Granted Under Long-Term Incentive Program (Detail) Sheet http://www.antarespharma.com/role/ShareBasedCompensationScheduleofPerformanceStockUnitAwardsandRestrictedStockGrantedUnderLongTermIncentiveProgramDetail Share Based Compensation - Schedule of Performance Stock Unit Awards and Restricted Stock Granted Under Long-Term Incentive Program (Detail) Details 57 false false R58.htm 2441422 - Disclosure - Share Based Compensation - Fair Value of PSUs Granted Determined Using Monte Carlo Simulation (Detail) Sheet http://www.antarespharma.com/role/ShareBasedCompensationFairValueofPSUsGrantedDeterminedUsingMonteCarloSimulationDetail Share Based Compensation - Fair Value of PSUs Granted Determined Using Monte Carlo Simulation (Detail) Details 58 false false R59.htm 2442423 - Disclosure - Share Based Compensation - Summary of Share Based Compensation Allocation Expense (Detail) Sheet http://www.antarespharma.com/role/ShareBasedCompensationSummaryofShareBasedCompensationAllocationExpenseDetail Share Based Compensation - Summary of Share Based Compensation Allocation Expense (Detail) Details 59 false false R60.htm 2444424 - Disclosure - Employee 401(k) Savings Plan - Additional Information (Detail) Sheet http://www.antarespharma.com/role/Employee401kSavingsPlanAdditionalInformationDetail Employee 401(k) Savings Plan - Additional Information (Detail) Details 60 false false R61.htm 2446425 - Disclosure - Sale of Assets - Additional Information (Detail) Sheet http://www.antarespharma.com/role/SaleofAssetsAdditionalInformationDetail Sale of Assets - Additional Information (Detail) Details 61 false false R62.htm 2449426 - Disclosure - Income Taxes - Schedule of Income (Loss) before Income Tax Domestic and Foreign (Detail) Sheet http://www.antarespharma.com/role/IncomeTaxesScheduleofIncomeLossbeforeIncomeTaxDomesticandForeignDetail Income Taxes - Schedule of Income (Loss) before Income Tax Domestic and Foreign (Detail) Details 62 false false R63.htm 2450427 - Disclosure - Income Taxes - Schedule of Income Tax Expense (Benefit) (Detail) Sheet http://www.antarespharma.com/role/IncomeTaxesScheduleofIncomeTaxExpenseBenefitDetail Income Taxes - Schedule of Income Tax Expense (Benefit) (Detail) Details 63 false false R64.htm 2451428 - Disclosure - Income Taxes - Summary of Effective Tax Rates Differ from Statutory Income Tax Rates (Detail) Sheet http://www.antarespharma.com/role/IncomeTaxesSummaryofEffectiveTaxRatesDifferfromStatutoryIncomeTaxRatesDetail Income Taxes - Summary of Effective Tax Rates Differ from Statutory Income Tax Rates (Detail) Details 64 false false R65.htm 2452429 - Disclosure - Income Taxes - Summary of Deferred Tax Assets (Liabilities) (Detail) Sheet http://www.antarespharma.com/role/IncomeTaxesSummaryofDeferredTaxAssetsLiabilitiesDetail Income Taxes - Summary of Deferred Tax Assets (Liabilities) (Detail) Details 65 false false R66.htm 2453430 - Disclosure - Income Taxes - Additional Information (Detail) Sheet http://www.antarespharma.com/role/IncomeTaxesAdditionalInformationDetail Income Taxes - Additional Information (Detail) Details 66 false false R67.htm 2454431 - Disclosure - Income Taxes - Unrecognized Tax Benefits (Detail) Sheet http://www.antarespharma.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetail Income Taxes - Unrecognized Tax Benefits (Detail) Details 67 false false R68.htm 2457432 - Disclosure - Revenues, Significant Customers and Concentrations of Risk - Summary of Revenue Disaggregated by Major Types and Sources (Detail) Sheet http://www.antarespharma.com/role/RevenuesSignificantCustomersandConcentrationsofRiskSummaryofRevenueDisaggregatedbyMajorTypesandSourcesDetail Revenues, Significant Customers and Concentrations of Risk - Summary of Revenue Disaggregated by Major Types and Sources (Detail) Details 68 false false R69.htm 2458433 - Disclosure - Revenues, Significant Customers and Concentrations of Risk - Summary of Significant Customers from which the Company Derived 10% or More of Total Revenue (Detail) Sheet http://www.antarespharma.com/role/RevenuesSignificantCustomersandConcentrationsofRiskSummaryofSignificantCustomersfromwhichtheCompanyDerived10orMoreofTotalRevenueDetail Revenues, Significant Customers and Concentrations of Risk - Summary of Significant Customers from which the Company Derived 10% or More of Total Revenue (Detail) Details 69 false false R70.htm 2461434 - Disclosure - Earnings (Loss) per Share - Summary of Computation for Basic and Diluted Net Earnings (Loss) per Share (Detail) Sheet http://www.antarespharma.com/role/EarningsLossperShareSummaryofComputationforBasicandDilutedNetEarningsLossperShareDetail Earnings (Loss) per Share - Summary of Computation for Basic and Diluted Net Earnings (Loss) per Share (Detail) Details http://www.antarespharma.com/role/EarningsLossperShareTables 70 false false R71.htm 2463435 - Disclosure - Commitments and Contingencies - Additional Information (Detail) Sheet http://www.antarespharma.com/role/CommitmentsandContingenciesAdditionalInformationDetail Commitments and Contingencies - Additional Information (Detail) Details 71 false false All Reports Book All Reports atrs-20211231.htm atrs-12312020x10kex311.htm atrs-12312020x10kex312.htm atrs-12312020x10kex321.htm atrs-12312020x10kex322.htm atrs-20211231.xsd atrs-20211231_cal.xml atrs-20211231_def.xml atrs-20211231_lab.xml atrs-20211231_pre.xml ex1014063995_x120506350v4x.htm ex1023projectgreatlakesapa.htm ex231atrskpmg2021consent.htm atrs-20211231_g1.jpg atrs-20211231_g2.jpg http://fasb.org/us-gaap/2021-01-31 http://xbrl.sec.gov/dei/2021q4 true true